It can treat metabolic dysfunction-associated fatty liver disease (MAFLD) by decreasing caspase-3 and p53 and increasing B-cell lymphoma 2 (Bcl-2) levels, which helps to reduce liver fat accumulation [111]. This evidence concerns the gene CASP3 and fatty liver disease.